We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Liquid Sensor Technology to Detect Cancer Instantly

By LabMedica International staff writers
Posted on 17 Mar 2010
It may be soon possible to go to the store and purchase a kit to diagnose cancer quickly and accurately, similar to a pregnancy test. More...
A researcher is developing a tiny sensor, known as an acoustic resonant sensor, smaller than a human hair that could test bodily fluids for a variety of diseases, including breast and prostate cancers.

"Many disease-related substances in liquids are not easily tracked,” said Dr. Jae Kwon, assistant professor of electrical and computer engineering at the University of Missouri (MU; Columbia, MO, USA). "In a liquid environment, most sensors experience a significant loss of signal quality, but by using highly sensitive, low-signal-loss acoustic resonant sensors in a liquid, these substances can be effectively and quickly detected--a brand-new concept that will result in a noninvasive approach for breast cancer detection.”

Dr. Kwon's real time, special acoustic resonant sensor uses micro/nanoelectromechanical systems (M/NEMS), which are tiny devices smaller than the diameter of a human hair, to detect directly diseases in body fluids. The sensor does not require bulky data reading or analyzing equipment and it can be integrated with equally small circuits, creating the potential for small stand-alone disease-screening systems. The sensor also produces fast, nearly immediate results that could reduce patient anxiety often felt after waiting for other detection methods, such as biopsies, which can take several days or weeks before results are known.

"Our ultimate goal is to produce a device that will simply and quickly diagnose multiple specific diseases, and eventually be used to create ‘point of care' systems, which are services provided to patients at their bedsides,” Dr. Kwon said. "The sensor has strong commercial potential to be manifested as simple home kits for easy, rapid, and accurate diagnosis of various diseases, such as breast cancer and prostate cancer.”

In January 2010, Kwon was awarded a US$400,000, five-year U.S. National Science (NSF) Foundation CAREER Award to continue his effort on this sensor research. The CAREER award is the NSF's most prestigious award in support of junior faculty members who exemplify the role of teacher-scholars through outstanding research, excellent teaching, and the integration of education and research.

Related Links:
University of Missouri


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Urine Analyzer
respons® UDS100
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: Signatera uses ctDNA analysis to identify residual tumor-derived genetic material after definitive treatment (image credit: Adobe Stock)

Blood-Based MRD Test Predicts Recurrence Risk After Lung Cancer Surgery

Assessing recurrence risk after surgery for early-stage non-small cell lung cancer remains challenging, complicating adjuvant therapy and surveillance decisions. Blood-based molecular residual disease... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Type 1 diabetes affects more than 9 million people worldwide and can begin years before symptoms appear, making early identification of at-risk children difficult (Image Credit: iStock)

Early-Life Gut Microbiome Changes May Help Assess Type 1 Diabetes Risk

Type 1 diabetes (T1D) affects more than 9 million people worldwide, including 1.8 million children and adolescents, and often begins years before symptoms appear. Early identification of children who are... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.